Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01856582 · ClinicalTrials.gov registry record · Phase 2
CD34+ Stem Cell Infusion to Augment Graft Function
A Phase 2 study, sponsored by Children's Hospital Medical Center, Cincinnati.
- Terminated
- Registry status
- Phase 2
- Development phase
- 23
- Enrollment target
NCT01856582 is a Phase 2 study that was terminated before completion, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 23 participants.
The verdict
NCT01856582, a Phase 2 study, was terminated before completion, sponsored by Children's Hospital Medical Center, Cincinnati.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 23 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if infusing additional special donor cells will help to improve graft or immune function in previously transplanted children with immune deficiencies and bone marrow failures.
Interventions
- BIOLOGICAL CD34+
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2010-10 |
| Est. Completion | 2018-08-15 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01856582
The ClinicalTrials.gov registry entry for NCT01856582 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital Medical Center, Cincinnati, which has 571 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CD34+ is the first listed.
NCT01856582 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01856582 about?
NCT01856582 is a clinical study titled "CD34+ Stem Cell Infusion to Augment Graft Function". The purpose of this study is to determine if infusing additional special donor cells will help to improve graft or immune function in previously transplanted children with immune deficiencies and bone marrow failures.
What is the current status of trial NCT01856582?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 23 participants. The study started on 2010-10. Estimated completion is 2018-08-15.
What interventions are being tested in trial NCT01856582?
The interventions under investigation include: CD34+ (BIOLOGICAL).
Who is sponsoring clinical trial NCT01856582?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.